RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
LUNG CANCER (AMSTERDAM, NETHERLANDS)
Collezione AO Cuneo

Items : 12

Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2019 Aug;134:210-217. doi: 10.1016/j.lungcan.2019.06.028. Epub 2019 Jun 27.

2019
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino

Novello S; Migliaretti G; Pacchiana MV; Stura I; Critelli R; Metro G; Morelli AM; Manzo A; Ricciardi S; Bria E; Colantonio I; Ciuffreda L; Pisconti S; Ceresoli GL; Del Conte A; Gregorc V; Scotti V; Galetta D; Romano G; Grossi F; Delmonte A; Costanzo FD; Tiseo M; Chiari R; Morabito A; Capelletto E; Migliorino MR;

Outcome of surgically resected thymic carcinoma: a multicenter experience. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2014 Feb;83(2):205-10. doi: 10.1016/j.lungcan.2013.11.015. Epub 2013 Nov 26.

2014
AO Cuneo

Venuta F; Oliaro A; Lyberis P; Terzi A; Rena O; Casadio C; Ibrahim M; Anile M; Vitolo D; Novero D; Ruco L; Ruffini E; Bora G; Rendina AE; Guerrera F; Filosso PL;

Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2011 Nov;74(2):239-43. doi: 10.1016/j.lungcan.2011.02.018. Epub 2011 Mar 25.

2011
AO Cuneo

Comino A; Biggi A; Bianchi A; Campione A; Luzzi L; Bertolaccini L; Rizzardi G; Terzi A;

Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC). in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2004 Sep;45(3):373-80. doi: 10.1016/j.lungcan.2004.01.023.

2004
AO Cuneo

Ferrigno D; Buccheri G;

Second-line weekly paclitaxel in patients with inoperable non-small cell lung cancer who fail combination chemotherapy with cisplatin. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2004 Aug;45(2):227-36. doi: 10.1016/j.lungcan.2004.01.011.

2004
AO Cuneo

Buccheri G; Ferrigno D;

Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC). in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2003 Sep;41(3):311-20. doi: 10.1016/s0169-5002(03)00232-0.

2003
AO Cuneo

Ferrigno D; Buccheri G; Giordano C;

Single-agent pegylated liposomal doxorubicin (Caelix) in chemotherapy pretreated non-small cell lung cancer patients: a pilot trial. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2002 Jan;35(1):59-64. doi: 10.1016/s0169-5002(01)00269-0.

2002
AO Cuneo

Gasco M; Ciura PL; Garrone O; Mariani G; Costanzo GD; Granetto C; Castiglione F; Numico G; Ostellino O; Porcile G; Merlano M;

Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy? in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2001 Jun;32(3):213-26. doi: 10.1016/s0169-5002(00)00222-1.

2001
AO Cuneo

Numico G; Russi E; Merlano M;

Lung tumor markers of cytokeratin origin: an overview. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2001 Dec;34 Suppl 2:S65-9. doi: 10.1016/s0169-5002(01)00347-6.

2001
AO Cuneo

Buccheri G; Ferrigno D;

Importance of weight loss definition in the prognostic evaluation of non-small-cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2001 Dec;34(3):433-40. doi: 10.1016/s0169-5002(01)00273-2.

2001
AO Cuneo

Buccheri G; Ferrigno D;

Serum biomarkers of non-neuron-endocrine origin in small-cell lung cancer: a 16-year study on carcinoembryonic antigen, tissue polypeptide antigen and lactate dehydrogenase. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2000 Oct;30(1):37-49. doi: 10.1016/s0169-5002(00)00123-9.

2000
AO Cuneo

Buccheri G; Ferrigno D;

Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference? in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2000 Aug;29(2):91-104. doi: 10.1016/s0169-5002(00)00112-4.

2000
AO Cuneo

Buccheri G; Ferrigno D;